Viscogliosi Bros
Financial Services, 100 North Tryon St, New York, 28255, United States, 51-200 Employees
Phone Number: 21********
Who is VISCOGLIOSI BROS
Viscogliosi Brothers, LLC (VB), headquartered in New York City, specializes in venture capital, private equity and merchant banking for the neuromusculoskeletal industry. Founded by Antho...
Read More
-
Headquarters: 100 North Tryon St, New York, New York, 28255, United States
-
Date Founded: 1999
-
Employees: 51-200
-
Revenue: $1 Billion and Over
-
Active Tech Stack: See technologies
-
CEO:
Nicole Kornas
Email
Phone
Industry: Financial Services
SIC Code: 6771
|
NAICS Code: 523910 |
Show More
Does something look wrong? Fix it. | View contact records from VISCOGLIOSI BROS
Viscogliosi Bros Org Chart and Mapping
Similar Companies to Viscogliosi Bros
O'Keefe
-
11-50
-
$ 50 Million to 100 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Viscogliosi Bros
Answer: Viscogliosi Bros's headquarters are located at 100 North Tryon St, New York, 28255, United States
Answer: Viscogliosi Bros's phone number is 21********
Answer: Viscogliosi Bros's official website is https://vbllc.com
Answer: Viscogliosi Bros's revenue is $1 Billion and Over
Answer: Viscogliosi Bros's SIC: 6771
Answer: Viscogliosi Bros's NAICS: 523910
Answer: Viscogliosi Bros has 51-200 employees
Answer: Viscogliosi Bros is in Financial Services
Answer: Viscogliosi Bros top competitors include: O'Keefe
Answer: Viscogliosi Bros contact info: Phone number: 21******** Website: https://vbllc.com
Answer: Viscogliosi Brothers, LLC (VB), headquartered in New York City, specializes in venture capital, private equity and merchant banking for the neuromusculoskeletal industry. Founded by Anthony, John and Marc Viscogliosi in 1999, the firm creates, builds, operates and finances companies founded on surgeon-developed innovation to address unmet clinical needs uniquely focused on life-changing neuromusculoskeletal technologies. VB principals have participated in more than 200 transactions, have invested in more than 20 companies and have formed nine industry-defining strategic partnerships. VB invests in technologies whose applications benefit patients and the healthcare system by improving quality of care, reducing costs, and expanding patient and provider access. With enhanced data, VB attempts to identify the technologies that best satisfy these criteria and works to transform them into successful medical breakthroughs that enable patients to regain active lifestyles. VB, its affiliates, and its partnerships have generated more than $1.5 billion in exit value on behalf of their shareholders and investor base. Through its portfolio companies, VB has defined five entirely novel orthopedic industry categories. Its investments have helped commercialize more than 75 med-tech devices, including ten number one orthopedic technologies. VB portfolio companies have sold products in more than 70 countries. VB invests its own capital in every venture, and is wholly committed to the operational, clinical, and financial success of each of its portfolio investments. Current portfolio companies within the VB ecosystem include, but are not limited to, Paradigm Spine, Centinel Spine, Woven Orthopedics Technology, Musculoskeletal Clinical Regulatory Advisers, and Aperion Biologics.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month